The new designer drug buphedrone produces rewarding properties via dopamine D1 receptor activation

Substituted cathinones are synthetic analogs of the active components of natural products and are widely abused worldwide. However, the rewarding properties of these agents have not yet been evaluated. In this study, we investigated the abuse potential of buphedrone [2‐(methylamino)‐1‐phenylbutan‐1‐one, α‐methylamino‐butyrophenone] and its effects on the mesolimbic dopaminergic system in mice using conditioned place preference (CPP) analysis, a self‐administration test, a locomotor activity test, a behavioral sensitization test and Western blot analysis. Treatment with buphedrone supported CPP and self‐administration, enhanced locomotor activity and produced behavioral sensitization when mice were challenged with methamphetamine. SCH23390, a D1 dopamine antagonist, prevented buphedrone‐induced CPP, whereas raclopride, a D2 dopamine antagonist, had no effect. SCH23390 also blocked locomotor activity increase by buphedrone, while raclopride partially attenuated locomotor activation. Western blot analysis revealed that repeated buphedrone treatment increased D1 dopamine receptor expression in the dorsal striatum and nucleus accumbens in mice. Collectively, these findings suggest the abuse potential of buphedrone and demonstrate the involvement of the dopaminergic system in the establishment of its rewarding properties.

[1]  R. A. Fuchs,et al.  Effects of intraaccumbens administration of SCH‐23390 on cocaine‐induced locomotion and conditioned place preference , 1998, Synapse.

[2]  K. Mizuno,et al.  Possible involvement of type 1 inositol 1,4,5-trisphosphate receptors up-regulated by dopamine D1 and D2 receptors in mouse nucleus accumbens neurons in the development of methamphetamine-induced place preference , 2012, Neuroscience.

[3]  G. Koob,et al.  Effects of Dose and Session Duration on Cocaine Self-Administration in Rats , 2007, Journal of Pharmacology and Experimental Therapeutics.

[4]  Sara R. Jones,et al.  Differential Influence of Dopamine Transport Rate on the Potencies of Cocaine, Amphetamine, and Methylphenidate , 2014, ACS chemical neuroscience.

[5]  M. Geyer,et al.  Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs. , 1989, NIDA research monograph.

[6]  Fang Liu,et al.  Dopamine transporter cell surface localization facilitated by a direct interaction with the dopamine D2 receptor , 2007, The EMBO journal.

[7]  R. Glennon.  Discriminative stimulus properties of phenylisopropylamine derivatives. , 1986, Drug and alcohol dependence.

[8]  S. Schenk,et al.  Sensitization and Tolerance in Psychostimulant Self-Administration , 1997, Pharmacology Biochemistry and Behavior.

[9]  F. Noble,et al.  Involvement of D1 dopamine receptor in MDMA-induced locomotor activity and striatal gene expression in mice , 2008, Brain Research.

[10]  Sara R. Jones,et al.  Cocaine Self-Administration Produces Pharmacodynamic Tolerance: Differential Effects on the Potency of Dopamine Transporter Blockers, Releasers, and Methylphenidate , 2012, Neuropsychopharmacology.

[11]  M. Kłyś,et al.  "New designer drugs" in aspects of forensic toxicology. , 2014, Archives of Forensic Medicine and Criminology.

[12]  Yun Wang,et al.  Differential modulation of methamphetamine-mediated behavioral sensitization by overexpression of Mu opioid receptors in nucleus accumbens and ventral tegmental area , 2015, Psychopharmacology.

[13]  I. Matsuoka,et al.  Effects of repeated methamphetamine administration on dopamine D1 receptor, D2 receptor and adenylate cyclase type V mRNA levels in the rat striatum , 1997, Neuroscience Letters.

[14]  Angus C Nairn,et al.  Cocaine-induced dendritic spine formation in D1 and D2 dopamine receptor-containing medium spiny neurons in nucleus accumbens. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  K. Kita,et al.  Effects of D1 and D2 dopamine receptor antagonists on cocaine-induced self-stimulation and locomotor activity in rats , 1999, European Neuropsychopharmacology.

[16]  C. Nicholson,et al.  Amphetamine Distorts Stimulation-Dependent Dopamine Overflow: Effects on D2 Autoreceptors, Transporters, and Synaptic Vesicle Stores , 2001, The Journal of Neuroscience.

[17]  A. Reitz,et al.  Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats. , 2013, Drug and alcohol dependence.

[18]  Jing Zhang,et al.  Melatonin treatment during the incubation of sensitization attenuates methamphetamine-induced locomotor sensitization and MeCP2 expression , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[19]  B. Blough,et al.  The Reinforcing and Rewarding Effects of Methylone, a Synthetic Cathinone Commonly Found in "Bath Salts" , 2012, Journal of addiction research & therapy.

[20]  S. A. McDougall,et al.  Effects of dopamine D1 and D2 receptor antagonists on cocaine-induced place preference conditioning in preweanling rats. , 1995, European journal of pharmacology.

[21]  D. Zuba,et al.  Detection of buphedrone in biological and non-biological material--two case reports. , 2013, Forensic science international.

[22]  M. Liechti,et al.  Monoamine transporter and receptor interaction profiles of a new series of designer cathinones , 2014, Neuropharmacology.

[23]  M. Zloh,et al.  An analysis of the 'legal high' mephedrone. , 2010, Bioorganic & medicinal chemistry letters.

[24]  B. J. Hatton,et al.  Effects of selective D1 and D2 dopamine antagonists on the development of behavioral sensitization to apomorphine , 2005, Psychopharmacology.

[25]  R. Kronstrand,et al.  Mephedrone, Methylone and 3,4‐Methylenedioxypyrovalerone (MDPV) Induce Conditioned Place Preference in Mice , 2014, Basic & clinical pharmacology & toxicology.

[26]  M. Liechti,et al.  Pharmacological characterization of designer cathinones in vitro , 2013, British journal of pharmacology.

[27]  J. Camarasa,et al.  Comparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methylone , 2012, British journal of pharmacology.

[28]  T. Tzschentke,et al.  Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues , 1998, Progress in Neurobiology.

[29]  Wei Xu,et al.  Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation. , 2012, Drug and alcohol dependence.

[30]  Daniel Maliniak,et al.  Prefrontal glutamate correlates of methamphetamine sensitization and preference , 2016, The European journal of neuroscience.

[31]  Henry A Spiller,et al.  Clinical experience with and analytical confirmation of “bath salts” and “legal highs” (synthetic cathinones) in the United States , 2011, Clinical toxicology.

[32]  M. Taffe,et al.  Intravenous self-administration of mephedrone, methylone and MDMA in female rats , 2015, Neuropharmacology.

[33]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[34]  F. Dorman,et al.  The analytical investigation of synthetic street drugs containing cathinone analogs. , 2014, Forensic science international.

[35]  K. Houseknecht,et al.  Mephedrone (4‐methylmethcathinone) supports intravenous self‐administration in Sprague‐Dawley and Wistar rats , 2013, Addiction biology.

[36]  Helen Young,et al.  Society for the study of addiction. , 1999, Addiction biology.

[37]  Kurt R. Lehner,et al.  Psychoactive "bath salts": not so soothing. , 2013, European journal of pharmacology.

[38]  Magalie Paillet-Loilier,et al.  Emerging drugs of abuse: current perspectives on substituted cathinones , 2014 .

[39]  Differential effects of intra-accumbens sulpiride on cocaine-induced locomotion and conditioned place preference. , 1996, The Journal of pharmacology and experimental therapeutics.

[40]  Daniel J. Peterson,et al.  The Role of Dopamine D1 and D2 Receptors in Adolescent Methylphenidate Conditioned Place Preference: Sex Differences and Brain-Derived Neurotrophic Factor , 2014, Developmental Neuroscience.

[41]  C. Jang,et al.  Dependence Potential of Tramadol: Behavioral Pharmacology in Rodents , 2012, Biomolecules & therapeutics.

[42]  C. Jang,et al.  Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches , 2014, Biomolecules & therapeutics.